Supernus Pharmaceuticals, Inc. (LON: 0LB2)
London
· Delayed Price · Currency is GBP · Price in USD 38.43
+0.82 (2.17%)
Jan 21, 2025, 2:47 PM BST
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of 1.71 billion as of January 23, 2025. Its market cap has increased by 45.47% in one year.
Market Cap
1.71B
Enterprise Value
1.41B
Revenue
486.44M
Ranking
n/a
PE Ratio
38.41
Stock Price
38.43
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from 79.17M to 1.71B, an increase of 2,061.61%. That is a compound annual growth rate of 27.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |